Figure 4. Immunodetection with TsCD146 mAb of CD146 expressed on microparticles in plasma samples from patients with melanoma.

Annexin V-positive/TsCD146-positive microparticles from plasmas of control patients and patients with melanoma at different disease stages were quantified. Control patients were compared to all melanoma patients (A) or to patients with melanoma at initial or metastatic stages (B). ^**p < 0.01, ^***p < 0.001 experimental versus control.